3,4-methylenedioxyamphetamine has been researched along with Brain Vascular Disorders in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Silva, RN | 1 |
| Harries, DP | 1 |
| Grange, SL | 1 |
| Castro, S | 1 |
| Owensby, S | 1 |
| Thorpe, M | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Brain Vascular Disorders
| Article | Year |
|---|---|
Misuse of ecstasy.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cerebrovascular Disorders; Designer Drugs; Humans; | 1992 |
Keeping the circle of love alive.
Topics: Adaptation, Psychological; Aged; Cerebrovascular Disorders; Coma; Family; Female; Humans; Love; Pati | 1996 |